Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple ascending-dose double-blind study of GAL-021 in healthy volunteers
NL-OMON41554Active, not recruiting
- Sponsor
- Galleon Pharmaceuticals, Inc
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind, single-arm trial of ENA-001 in respiratory failure, sponsored by Galleon Pharmaceuticals, Inc. Primary endpoints: Safety and tolerability, Pharmacokinetics of GAL-021 and 1 more. Started Oct 2013; status: active, not recruiting.
02
Drugs
ENA-001
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NL-OMON41554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41554.